Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2008
10/09/2008WO2007100566A3 Use of dha and ara in the preparation of a composition for regulating gene expression
10/09/2008WO2007041364A3 Conjugates for modulating the immune tolerance
10/09/2008US20080249298 use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids
10/09/2008US20080249173 Treatment of Apoptosis
10/09/2008US20080249157 Novel Inhibitors of the Lfa-1/Icam-1 Interaction and Uses Thereof
10/09/2008US20080249147 Emulsion-Stabilized Preparation
10/09/2008US20080249138 Pyridine Compounds For The Treatment Of Prostaglandin Mediated Diseases
10/09/2008US20080249111 Piperdine Derivatives as CCR5 Inhibitors
10/09/2008US20080249098 peripheral benzodiazepine receptors; 7-fluoro-N,N,5-trimethyl-4-oxo-3-(pyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide; for the treatment of various types of peripheral neuropathies, amyotrophic lateral sclerosis
10/09/2008US20080249093 immunosuppressive, anti-inflammatory and hemostatic agents to modulate leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity; safer and more effective; 3-(4-(5-(3-Cyano-4-isopropyloxyphenyl)-1,2,4-oxadiazol-3-yl)-3-methylphenyl)propanoic acid
10/09/2008US20080249077 glucocorticoid receptor agonists; to treat inflammatory and allergic conditions; Fluoromethyl(6 alpha ,11 beta ,16 alpha ,17 alpha )-17-({[(1,1-dimethylethyl)oxy]carbonyl}oxy)-6,9-difluoro-11-hydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylate
10/09/2008US20080249070 potent, and selective agonists for G protein-coupled receptors (S1P1); to treat autoimmune diseases, such as, uveitis, type I diabetes, rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, cancer, neurodegenerative diseases; (1-amino-3-(4-octylphenyl cyclopentyl)methanol
10/09/2008US20080249067 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP)
10/09/2008US20080249037 having biological activity similar to PIM (acyl glycerol phosphatidylinositol manno-oligosacccharide) activity; asthma, allergic rhinitis, dermatitis, psoriasis, inflammatory bowel disease including Crohn's disease and ulcerative colitis, rheumatoid arthritis, multiple sclerosis, diabetes, systemic lupus
10/09/2008US20080249010 Method Of Inducing Apoptosis In Lymphoid Cells
10/09/2008US20080248992 Inactivated alpha-cobratoxin; neurotoxins affecting neurojunction, ion channels; inactive bioactive polypeptide of anti-immunodeficiency virus immunokine binding to a cellular protein that reduces HIV infection; identification of a biologic anticholinergic agent capable of binding to a cellular protein
10/09/2008US20080248123 zolpidem, phenytoin; controlled release; surface modifier selected from anionic surfactants, cationic surfactants, zwitterionic surfactants, nonionic surfactants, surface active biological modifiers; hydroxypropyl methyl cellulose, hydrogenated oil or polyvinylpyrrolidone as rate controlling polymer
10/09/2008US20080248094 Vaccine adjuvant properties of lipsomes formed at elevated temperatures from the polar chloroform extractable lipids from mycobacterium bovis
10/09/2008US20080248068 Use of Flagellin as an Adjuvant for Vaccine
10/09/2008US20080248067 Immunomodulating Compositions and Uses Therefor
10/09/2008US20080248061 vaccine against porcine circovirus type 2 (PCV-)2 and a method for the manufacture of such a vaccine, for protecting piglets against PCV-2 infection.
10/09/2008US20080248060 Adenoviral vector-based malaria vaccines
10/09/2008US20080248056 Immunomodulatory Product Obtained from a Bifidobacterium Culture and Compositions Containing the Same
10/09/2008US20080248050 Meta-specific vaccine, method for treating patients immunized with meta-specific vaccine
10/09/2008US20080248045 Polypeptides having a triggering nk activity and biological applications
10/09/2008US20080248044 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination
10/09/2008US20080248042 Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc
10/09/2008US20080248031 Cell surface molecule mediating cell adhesion and signal transmission
10/09/2008US20080248029 Prevention and treatment of amyloidogenic diseases
10/09/2008US20080248025 Gamma Delta T Cells and Methods of Treatment of Interleukin-17 Related Conditions
10/09/2008US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein
10/09/2008US20080248008 Transferase inhibitory mimetic for use in treatment and prevention of immunosuppressive, cell proliferative and autoimmune disorders
10/09/2008US20080248007 Nucleotide sequences coding protein associated with immune response for use in identifying modulators for prevention and treatment of immunodeficiency, autoimmue and inflammatory disorders
10/09/2008US20080247994 DNA vaccine
10/09/2008US20080247955 Detecting secreted phosphoprotein-1 and/or biomarkers; autoimmune diseases; antibodies; RNA interference
10/09/2008US20080247953 Drug screening assays; SH2 docking domains; signal sequences; immunology; cyclophilins
10/09/2008CA2682646A1 Pyrrolopyrimidine derivatives as jak3 inhibitors
10/09/2008CA2682525A1 Production of a viable, storable worm egg suspension
10/09/2008CA2682375A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous activity
10/09/2008CA2682370A1 Process for the manufacture of a dairy-based anti-inflammatory composition
10/09/2008CA2682199A1 Chloroplasts engineered to express pharmaceutical proteins in edible plants
10/09/2008CA2681979A1 Indole derivatives having cpla2 inhibiting activity and applications and production methods of the same
10/09/2008CA2681752A1 Crystalline anti-human 1l-12 antibodies
10/08/2008EP1978362A2 Cross beta structure comprising amyloid binding proteins and methods for detection of the cross beta structure, for modulating cross beta structures fibril formation and for modulating cross beta structure-mediated toxicity
10/08/2008EP1978097A1 Regulation of transcription factor, NF-IL6/LAP
10/08/2008EP1978096A1 Novel oligonucleotide and nf-kappa b decoy comprising the same
10/08/2008EP1978029A2 Secreted and transmembrane polypeptides and nucleic acids endoding the same
10/08/2008EP1977755A1 Shrimp allergen antishrimp allergen antibody and use thereof
10/08/2008EP1977643A1 Manufacture of a viable, storable worm egg suspension
10/08/2008EP1976883A2 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
10/08/2008EP1976833A2 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors
10/08/2008EP1976564A2 Immuno-rna-constructs
10/08/2008EP1976542A1 Therapeutic use of an extract from the leaves of nerium oleander
10/08/2008EP1976512A1 Novel thiophene derivatives as s1p1/edg1 receptor agonists
10/08/2008EP1976506A1 Cannabinoid-containing plant extracts as neuroprotective agents
10/08/2008EP1976397A2 Infant immunological formula
10/08/2008EP1976396A2 Composition comprising polyunsaturated fatty acids for improving membrane composition
10/08/2008EP1976395A2 Composition comprising polyunsaturated fatty acids for improving membrane composition
10/08/2008EP1592452B1 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology
10/08/2008EP1539693B9 Cannabinoid receptor agonists
10/08/2008EP1469000B1 Novel crystalline tricyclic triazolobenzazepine derivative
10/08/2008EP1392323B1 Use of a vitamin d3 analogue for the treatment of autoimmune diabetes
10/08/2008EP1189626B1 Composition for preventing tumoral growth
10/08/2008EP1140165B1 Improved saponin adjuvant compositions and methods relating thereto
10/08/2008EP1064298B1 Inhibitors of caspases
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008EP0752005B1 Compacted nucleic acids and their delivery to cells
10/08/2008CN101282994A Anti-CD26 antibodies and methods of use thereof
10/08/2008CN101282960A RAF inhibitor compounds and methods
10/08/2008CN101282745A B-cell reduction using CD37-specific and CD20-specific binding molecules
10/08/2008CN101282732A Composition containing fucoidan or fucoidan hydrolysate and immunopotentiating material
10/08/2008CN101282719A Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders
10/08/2008CN101281199A Detection for discovering conventional medicine immunoregulating action as well as screening platform
10/08/2008CN101280288A Space efficient microbial strain of 20th recoverable satellite, preparation and application thereof
10/08/2008CN101280287A Space efficient microbial strain of 21st recoverable satellite, preparation and application thereof
10/08/2008CN101280286A Space efficient microbial strain of 22nd recoverable satellite, preparation and application thereof
10/08/2008CN101280026A Use of polysaecharide from the eggs of strongylocentrotus nudus with alpha-1,4-dextran chain
10/08/2008CN101279955A N-substituted thiamorpholine derivate as DPP-IV inhibitor and medical use thereof
10/08/2008CN101279915A Substituted phenol and application thereof as receptor TR3 excitant
10/08/2008CN101279094A Treatment of T-cell mediated diseases
10/08/2008CN101279092A Applications of VEGF receptor fusion protein in preparation of medicament for curing diseases about angiogenesis
10/08/2008CN101279090A Method for extracting cacti SOD by combination of direct extraction and ultrasonic extraction
10/08/2008CN101279081A Chinese medicine for improving microcirculation and immunity of human body and processing method
10/08/2008CN101278993A Method for extracting triterpenes from jujube fruit
10/08/2008CN101278991A Method for testing effective ingredients of Gegen Qinlian medicine
10/08/2008CN101278968A Compound preparations with anticancer auxiliary function
10/08/2008CN101278967A Health care capsules for overall regulating immunity of organism and preparation technique
10/08/2008CN101278954A Ginseng or American ginseng product with increased content of ginseng saponin Rg3 and method of preparing the same
10/08/2008CN101278951A Chinese chestnut health care capsule
10/08/2008CN101278949A Composition and its preparation and application
10/08/2008CN101278947A Yellow-back fungus fermentation product, composition containing the fermentation product and preparation method thereof
10/08/2008CN100424182C Methods for detecting and treating the early onset of aging-related conditions
10/08/2008CN100423777C Glycoprotein compositions
10/08/2008CN100423776C Therapeutic agent
10/08/2008CN100423737C Liquor for improving function of human immunity
10/08/2008CN100423723C Method for treatment of multiple sclerosis
10/08/2008CN100423721C Thrombopoietin mimetics
10/07/2008US7433788 Crystallization of IGF-1
10/07/2008US7432375 JNK inhibitors
10/07/2008US7432374 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
1 ... 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 ... 1172